Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials

Saved in:

Bibliographic Details
Main Authors:	April W. Armstrong, Matthias Augustin, Jennifer L. Beaumont, Tan P. Pham, Stacie Hudgens, Kenneth B. Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M. Kisa, Subhashis Banerjee, Kim A. Papp
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-03-01
Series:	Dermatology and Therapy
Online Access:	https://doi.org/10.1007/s13555-024-01317-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet